The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens

scientific article published on 01 July 2019

The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S13046-019-1282-0
P932PMC publication ID6604380
P698PubMed publication ID31262325

P2093author name stringYuh-Ling Chen
Tse-Ming Hong
Shuenn-Chen Yang
Yi-Ying Wu
Keng-Fu Hsu
Jia-En Wu
Chao-Jung Tsao
Hung-Chang Wu
Kuo-Yen Huang
Si-Xuan Chen
P4510describes a project that usesImageJQ1659584
P433issue1
P304page(s)282
P577publication date2019-07-01
P1433published inJournal of Experimental & Clinical Cancer ResearchQ13739415
P1476titleThe dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens
P478volume38